FIG. 151 Ethmoid bone from behind. FIG. 152 Ethmoid bone from the right side. FIG. 153 Lateral wall of nasal cavity, showing ethmoid bone in position. In front of the lamina papyracea are some broken air cells which are overlapped and completed by the lacrimal bone and the frontal process of the maxilla.IG. 151 Ethmoid bone from behind. FIG. 152 Ethmoid bone from the right side. FIG. 153 Lateral wall of nasal cavity, showing ethmoid bone in position. In front of the lamina papyracea are some broken air cells which are overlapped and completed by the lacrimal bone and the frontal process of the maxilla.
Nusinersen sodium is administered intrathecally.1. 1  Dosing Information1. 2  Available as nusinersen sodium; dosage expressed in terms of nusinersen.1. 3  The recommended dosage is 12 mg (5 mL) per administration. 1.
Spinraza is designed to treat the underlying defect in SMA, which means it potentially may be effective at slowing, stopping or perhaps reversing the symptoms of SMA. For more, see Spinraza is Approved. For more, see Research, SMA: Full Speed Ahead and In Focus: Spinal Muscular Atrophy (SMA)